0591-3982
Generic: celecoxib
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
celecoxib
Labeler
actavis pharma, inc.
Dosage Form
CAPSULE
Active Ingredients
celecoxib 50 mg/1
Identifiers & Regulatory
Product NDC
0591-3982
Product ID
0591-3982_909300ab-8281-4b94-90c6-c124316e9faa
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2015-03-12
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05913982
Hyphenated Format
0591-3982
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
celecoxib (source: label)
Generic Name
celecoxib (source: ndc)
Application Number
ANDA200562 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 50 mg/1
Packaging
- 28735 CAPSULE in 1 CONTAINER (0591-3982-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "909300ab-8281-4b94-90c6-c124316e9faa", "openfda": {}, "finished": false, "packaging": [{"description": "28735 CAPSULE in 1 CONTAINER (0591-3982-00)", "package_ndc": "0591-3982-00", "marketing_start_date": "12-MAR-15"}], "product_id": "0591-3982_909300ab-8281-4b94-90c6-c124316e9faa", "dosage_form": "CAPSULE", "product_ndc": "0591-3982", "generic_name": "Celecoxib", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "CELECOXIB", "strength": "50 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20150312", "listing_expiration_date": "20261231"}